<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="6067">Isotretinoin</z:chebi>-induced keloid formation has occasionally been reported in patients who have undergone dermabrasion or laser treatment </plain></SENT>
<SENT sid="1" pm="."><plain>This report describes a man with <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD) who was prescribed <z:chebi fb="0" ids="6067">isotretinoin</z:chebi> for nodulocystic <z:hpo ids='HP_0001061'>acne</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>After approximately 8 weeks of this treatment, the patient developed extensive <z:hpo ids='HP_0010562'>keloids</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>There are no previous reports of possible <z:chebi fb="0" ids="6067">isotretinoin</z:chebi>-induced keloid formation in the setting of BD </plain></SENT>
<SENT sid="4" pm="."><plain>This article discusses possible connections between BD, keloid formation and <z:chebi fb="0" ids="6067">isotretinoin</z:chebi>, which may be manifested in this case </plain></SENT>
</text></document>